In this episode, we sit down with Dr. Abdelrahman Mahmoud, CEO & Founder of CellRewire, to explore a bold new vision for medicine: predictive and reprogrammable biology. What if AI could read the language of our cells, predict disease years before it emerges, and even reprogram cells back to a healthy state? We dive into CellRewire's groundbreaking Cell-DRL agent (Cellular Deep Reinforcement Learning), how it generates novel reprogramming therapies, and how AI can design targeted gene programs and interventions to guide diseased cells back to health.Whether you're into biotech, AI, or the future of medicine, this one's for you.Learn more about CellRewire: https://www.cellrewire.comLearn more about Transcribed: https://transcribedpod.com